Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in rabbits

被引:8
作者
Ferron, GM [1 ]
Jusko, WJ [1 ]
机构
[1] SUNY Buffalo, Dept Pharmaceut, Buffalo, NY 14260 USA
关键词
prednisolone; sirolimus; immunosuppressant; interaction; pharmacokinetics; pharmacodynamics; rabbit;
D O I
10.1023/A:1011966308791
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To assess pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone (Pred, 1 mg/kg) and sirolimus (Sir, 0.25 mg/kg) in rabbits. Methods. After intravenous administration, plasma concentrations of Pred and corticosterone, and Sir blood concentrations were followed for 24 hours along with blood granulocyte and T-helper cell counts. Ex vivo and in vitro whole blood lymphocyte proliferation marked lymphocyte reactivity. Results. Pred terminal half-life and clearance were 1.1 hr and 0.72 l/hr/kg with no difference after Sir. Sir values were 13 hr and 0.16 l/hr/kg and Pred produced no changes, Corticosterone production (0-12 hr) was suppressed by 55% after Pred alone or combined, while Sir did not cause adrenal suppression. Blood T-helper cells and granulocytes displayed circadian rhythms after placebo. Over 12 hr, T-helper cell counts were decreased by Pred (40%) and Sir (19%) while granulocyte numbers increased by 568 and 23%. After coadministration, cell numbers were similar to Pred alone. Pred and Sir decreased lymphocyte reactivity by 41% and 56% over 24 hr and their combination reached 85% inhibition with additive interaction. In vitro studies showed antagonistic or synergistic interactions depending on drug concentration ratios. Conclusions, At therapeutic concentrations, Sir and Pred do not significantly interact pharmacokinetically and have additive pharmacoimmunodynamics. Thus, the therapeutic application of this combinaison is promising.
引用
收藏
页码:1888 / 1894
页数:7
相关论文
共 29 条
[1]  
BOUMPAS DT, 1991, CLIN EXP RHEUMATOL, V9, P413
[2]  
Chow FS, 1997, DRUG METAB DISPOS, V25, P610
[3]  
DREWINKO B, 1976, CANCER BIOCHEM BIOPH, V1, P187
[4]  
Ferron GM, 1998, J PHARMACOL EXP THER, V286, P191
[5]  
Ferron GM, 1998, DRUG METAB DISPOS, V26, P83
[6]   Lipophilic benzamide and anilide derivatives as high-performance liquid chromatography internal standards: application to sirolimus (rapamycin) determination [J].
Ferron, GM ;
Conway, WD ;
Jusko, WJ .
JOURNAL OF CHROMATOGRAPHY B, 1997, 703 (1-2) :243-251
[7]  
FREY BM, 1984, J IMMUNOL, V133, P2479
[8]  
FREY FJ, 1983, J LAB CLIN MED, V101, P593
[9]   PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING - PRINCIPLES AND APPLICATIONS [J].
GERLOWSKI, LE ;
JAIN, RK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (10) :1103-1127
[10]  
GRECO WR, 1990, CANCER RES, V50, P5318